Bluebook
Diagnostics and Tools June 2024
2024 - June: Report on M&A and financing activity in the diagnostics and tools industry for CEOs and private equity professionals
Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.
Highlights from this edition:
- Moleculent closed a $26MM Series A Financing, led by Arch Venture Partners
- RareCyte closed a $20MM Growth Financing, led by Agilent Technologies, Inc. (NYSE:A), 5AM Venture Management, Arboretum Ventures, HealthQuest Capital, Impresa Management, Forest Road Company, Sheatree Capital, Gkcc
- BillionToOne, Inc. closed a $130MM Series D Financing, led by Premji Invest Limited